| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/16/2005 | US20050130127 Coronavirus-like particles comprising functionally deleted genomes |
| 06/16/2005 | US20050129702 Tick chitinase |
| 06/16/2005 | US20050129688 Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms thereof, pharmaceutical compositions containing, and use thereof as immunosuppressants |
| 06/16/2005 | US20050129657 Interferon-alpha induced gene |
| 06/16/2005 | US20050128842 Annular magnetic nanostructures |
| 06/16/2005 | CA2548942A1 Anti-sars monoclonal antibodies |
| 06/16/2005 | CA2548381A1 Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target |
| 06/16/2005 | CA2548185A1 Expression systems using mammalian .beta.-actin promoter |
| 06/16/2005 | CA2548135A1 Synthetic hla binding peptide analogues and uses thereof |
| 06/16/2005 | CA2547885A1 Methods for obtaining gene tags |
| 06/16/2005 | CA2547655A1 Novel centromeric protein shugoshin |
| 06/16/2005 | CA2546452A1 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens |
| 06/15/2005 | EP1542018A2 Method for detecting proteins |
| 06/15/2005 | EP1542012A1 Antibodies for detecting efavirenz |
| 06/15/2005 | EP1541688A1 Novel peptide synthase gene |
| 06/15/2005 | EP1541686A1 CONSTRUCTION OF ANTIBODY USING MRL/lPR MOUSE |
| 06/15/2005 | EP1541682A2 Generation and selection of recombinant varied binding proteins |
| 06/15/2005 | EP1541680A1 Antibody against n-terminal peptide or c-terminal peptide of gpc3 solubilized in blood |
| 06/15/2005 | EP1541036A1 Algae feeds for aquaculture and agriculture |
| 06/15/2005 | EP1540673A2 Metalized polyester film with heat-seal layer on opposite side for flyback transformer application |
| 06/15/2005 | EP1540559A2 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 06/15/2005 | EP1540349A1 Process for differential diagnosis of alzheimer s dementia i n patients exhibiting mild cognitive impairment |
| 06/15/2005 | EP1539989A2 Synthesis of glycoproteins using bacterial gycosyltransferases |
| 06/15/2005 | EP1539983A2 Methods for efficient production of mammalian recombinant proteins |
| 06/15/2005 | EP1539982A2 Glutathione production |
| 06/15/2005 | EP1539968A2 Plastid genetic engineering via somatic embryogenesis |
| 06/15/2005 | EP1539966A1 Protein production method |
| 06/15/2005 | EP1539962A1 Polyene polyketides and methods of production |
| 06/15/2005 | EP1539948A1 Improved methods of in vitro protein synthesis |
| 06/15/2005 | EP1539947A2 Humanized rabbit antibodies |
| 06/15/2005 | EP1539944A2 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 06/15/2005 | EP1539942A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 06/15/2005 | EP1539941A2 Adzymes and uses thereof |
| 06/15/2005 | EP1539819A2 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 06/15/2005 | EP1539809A2 Hcv fusion proteins with modified ns3 domains |
| 06/15/2005 | EP1539805A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer |
| 06/15/2005 | EP1539794A2 Benzoate- and anthranilate-inducible promoters |
| 06/15/2005 | EP1539237A2 Humanized antibodies against human 4-1bb |
| 06/15/2005 | EP1539233A1 Super humanized antibodies |
| 06/15/2005 | EP1539228A2 Novel composition and methods for the treatment of immune related diseases |
| 06/15/2005 | EP1538900A2 Cancer vaccines containing epitopes of oncofetal antigen |
| 06/15/2005 | EP1370571B1 Methods and apparatus for gel-free qualitative and quantitative proteome analysis, and uses therefor |
| 06/15/2005 | EP1276496B1 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 06/15/2005 | EP1261641A4 Diagnostic method using expression of mn/ca9 protein in agus pap smears |
| 06/15/2005 | EP1066059B1 Formulations for protection of peg-interferon alpha conjugates |
| 06/15/2005 | EP0998556B1 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1) |
| 06/15/2005 | EP0914344B1 ASSAY AND REAGENTS FOR QUANTIFYING hBNP |
| 06/15/2005 | CN1628179A Gene and protein relating to hepatocellular carcinoma |
| 06/15/2005 | CN1628176A Methods for large scale protein production in prokaryotes |
| 06/15/2005 | CN1628169A Artificial human chromosome containing human antibody lambda light chain gene |
| 06/15/2005 | CN1628168A Methods and materials for the production of organic products in cells of dollar i(candida) species |
| 06/15/2005 | CN1628129A Stabilization of protein preparations |
| 06/15/2005 | CN1628126A Modified transferrin fusion proteins |
| 06/15/2005 | CN1626669A Preparation of full-length human antibody |
| 06/15/2005 | CN1626662A Genes for the synthesis of antipathogenic substances |
| 06/15/2005 | CN1626649A Method for preparing protein of visual purple and dedicated strain |
| 06/15/2005 | CN1626552A Angiogenesis related molecules |
| 06/15/2005 | CN1626550A Excreted proteins as indicators related to tumor and application |
| 06/15/2005 | CN1206352C Usage of xylanase for prepn. of foods |
| 06/15/2005 | CN1206343C Pseudomycin production by i(pseudomonas syringae) |
| 06/15/2005 | CN1206303C Method for preparing hydrolytic gelatin using combine enzyme |
| 06/15/2005 | CN1206241C Novel natural antibacterial peptide, its code sequence and application |
| 06/15/2005 | CN1206237C Low allergenic proteinvariants |
| 06/15/2005 | CN1205873C Process for producing soybean protein hydrolyzate |
| 06/14/2005 | US6906176 Polypeptide or use in the fibrinolysis, digestion and coagulation |
| 06/14/2005 | US6906175 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor. |
| 06/14/2005 | US6906174 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 06/14/2005 | US6906170 Anti-inflammatory peptides derived from IL-2 and analogues thereof |
| 06/14/2005 | US6906169 Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide |
| 06/14/2005 | US6905868 Cleaning compounds; animal feeds |
| 06/14/2005 | US6905856 Soluble GlcNAc phosphotransferase |
| 06/14/2005 | US6905847 Method of increasing product expression through solute stress |
| 06/14/2005 | US6905846 Nucleic acids encoding factor X deletion mutants and analogues thereof |
| 06/14/2005 | US6905845 Isolated nucleic acids; allergies sensitivity |
| 06/14/2005 | US6905844 Human cervical cancer 2 protooncogene and protein encoded therein |
| 06/14/2005 | US6905843 Preparation containing cell extracts for synthesizing cell-free protein and means for synthesizing cell-free protein |
| 06/14/2005 | US6905842 Modulation signal transduction; isolated nucleic acids; genetic engineering |
| 06/14/2005 | US6905818 Detection cloning; isolation hybrids; using labels; genetic engineering |
| 06/14/2005 | US6905687 Fusion proteins; immunogens; solid phase synthesis; kits |
| 06/14/2005 | US6905685 Antiproliferative agents; monoclonal antibodies; blocking immunology response; autoimmune disease, antidiabetic agents, antiarthritic agents, antitumor, anticancer agents |
| 06/14/2005 | US6905684 Preventives and remedies for diffuse lung diseases |
| 06/14/2005 | US6905683 Prevents side effects such as systemic activation of coagulation system, bleeding |
| 06/14/2005 | US6905676 Cytokines; anttumor agents; viricides; bactericides; antiinflammatory agents |
| 06/14/2005 | CA2400318C Botulinum toxin pharmaceutical compositions |
| 06/14/2005 | CA2308142C Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them |
| 06/14/2005 | CA2284100C New gene with upregulated expression in metastatic human tumor cells and a protein coded thereby, methods of production, and use thereof |
| 06/14/2005 | CA2264585C Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions |
| 06/14/2005 | CA2100423C Parathyroid hormone analogs having parathyroid hormone-like activity |
| 06/10/2005 | CA2489266A1 Reagents for detecting efavirenz |
| 06/09/2005 | WO2005052186A1 Means and methods for the determination of camp in vitro and in vivo |
| 06/09/2005 | WO2005052177A1 Process for producing dipeptide |
| 06/09/2005 | WO2005052153A1 Process for producing dipeptide |
| 06/09/2005 | WO2005052151A1 Improved protein expression systems |
| 06/09/2005 | WO2005052117A2 Improved methods of in vitro protein synthesis |
| 06/09/2005 | WO2005052001A2 Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation |
| 06/09/2005 | WO2005052000A2 Anti-il-20 antibodies and binding partners and methods of using in inflammation |
| 06/09/2005 | WO2005051994A2 Ztnf11, a tumor necrosis factor |
| 06/09/2005 | WO2005051985A2 Methods for purifying pertussis toxin and peptides useful therefor |
| 06/09/2005 | WO2005051977A2 Conditional allele system |
| 06/09/2005 | WO2005051291A2 B-cell-targeted toxin for immuno response reduction |